Effects of anti-arthritis preparations on gene expression and enzyme activity of cyclooxygenase-2 in cultured equine chondrocytes

American Journal of Veterinary Research

Volumn 63, Issue 8, 2002, Pages 1134-1139

  Tung, Jayne T ^a   Venta, Patrick J ^a   Eberhart, Susan W ^a   Yuzbasiyan Gurkan, Vilma ^a   Alexander, Lee ^a   Caron, John P ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; COMPLEMENTARY DNA; CYCLOOXYGENASE 2; DEXAMETHASONE; GLYCOSAMINOGLYCAN POLYSULFATE; HYALURONIC ACID; PHENYLBUTAZONE; PROSTAGLANDIN E2; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT INTERLEUKIN 4;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; CULTURE TECHNIQUE; DNA PROBE; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; GENE AMPLIFICATION; GENE EXPRESSION; HORSE; IMMUNOASSAY; NONHUMAN; NORTHERN BLOTTING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOTTING, NORTHERN; CARTILAGE, ARTICULAR; CHONDROCYTES; CYCLOOXYGENASE 2; DEXAMETHASONE; DINOPROSTONE; ENZYME INDUCTION; GLYCOSAMINOGLYCANS; HORSES; HYALURONIC ACID; INTERLEUKIN-1; ISOENZYMES; PHENYLBUTAZONE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 0036701569     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2002.63.1134     Document Type: Article

References (44)

1. O'Banion MK, Sadowski HB, Winn V, et al. A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem 1991;266:23261-23267.
2. Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A 1992;89:7384-7388.
3. 2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985;162: 2163-2168.
4. O'Sullivan MG, Huggins EMJ, Meade EA, et al. Lipopolysaccharide priming of alveolar macrophages for enhanced synthesis of prostanoids involves induction of a novel prostaglandin H synthase. J Biol Chem 1992;267:14547-14550.
5. Gilman SC. Activation of rabbit articular chodrocytes by recombinant human cytokines. J Rheumatol 1987;14:1002-1007.
6. Lippiello L, Yamamoto K, Robinson D, et al. Involvement of prostaglandin from rheumatoid synovium and inhibition of articular cartilage metabolism. Arthritis Rheum 1978;21:909-917.
7. Tietz CC, Chrisman OD. The effect of salicylate and chloroquine on prostaglandin-induced articular damage in the rabbit knee. Clin Orthop 1975;108:26-274.
8. Robinson DR, Tashijian HJ, Levine L. Prostaglandin-stimulated bone resorption by rheumatoid synovia: a possible mechanism for bone destruction in rheumatoid arthritis. J Clin Invest 1975:56: 1181-1198.
9. Steinberg JJ, Hubbard JR, Sledge CB. Chondrocyte-mediated breakdown of cartilage. J Rheumatol 1993;20:325-330.
10. 2-dependent collagenase gene expression through their action on cyclooxygenase-2 and cytosolic phospholipase A2. Lab Invest 1996;75:529-538.
11. 1 inhibit cytokine induced metalloprotease expression in human synovial fibroblasts. Lab Invest 1994;71:270-278.
12. 2 on recombinant equine interleukin-1β-stimulated matrix metalloproteinases 1, 3, and 13 and tissue inhibitor of matrix metalloproteinase 1 expression in equine chondrocyte cultures. Am J Vet Res 2002;in press.
13. Kunkel S, Chensue S. Arachidonic acid metabolites regulate interleukin-1 production. Biochem Biophys Res Commun 1985;128: 892-897.
14. Dingle J. Prostaglandins in human cartilage metabolism. J Lipid Med 1993;6:310-312.
15. Caron JP, Tardif G, Martel-Pelletier J, et al. Modulation of matrix metalloprotease 13 (collagenase 3) gene expression in equine chondrocytes by IL-1 and corticosteroids. Am J Vet Res 1996;57: 1631-1634.
16. Boerboom D, Sirois J. Molecular characterization of equine prostaglandin G/H synthase-2 and regulation of its messenger ribonucleic acid in preovulatory follicles. Endocrinology 1998;139:1662-1670.
17. Morisset S, Patry C, Lora M, et al. Regulation of cyclooxygenase-2 expression in bovine chondrocytes in culture by interleukin-1α, tumor necrosis factor-α, glucocorticoids, and 17β estradiol. J Rheumatol 1998;25:1146-1153.
18. 2 stimulation. Exp Cell Res 1996;222:379-384.
19. Crofford LJ, Wilder RL, Ristimaki AP, et al. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1β, phorbol ester, and corticosteroids. J Clin Invest 1994;93:1095-1101.
20. Szczepanski A, Moatter T, Carley WW, et al. induction of cyclooxygenase II in human synovial microvessel endothelial cells by interleukin-1. Arthritis Rheum 1994;37:495-503.
21. Amin AR, Attur M, Patel R, et al. Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide. J Clin Invest 1997;99:1231-1237.
22. Geng Y, Blanco FJ, Cornelisson M, et al. Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes. J Immunol 1995;155:796-801.
23. Fu J-Y, Masferrer JL, Sebert K, et al. The induction and suppression of prostaglandin H synthase (cyclooxygenase) in human monocytes. J Biol Chem 1990;265:16737-16740.
24. Wissink S, van Heerde EC, vand der Burg B, et al. A dual mechanism mediates repression of NF-kappaB activity by glucocorticoids. Mol Endocrinol 1998;12:355-363.
25. Newton R, Hart LA, Stevens DA, et al. Effect of dexamethasone on interleukin-1beta(IL-1beta)-induced nuclear factor-kappaB(NF-kappaB) and KappaB-dependent transcription in epithelial cells. Eur J Biochem 1998;254:81-89.
26. Lasa M, Brook M, Saklatvala J, et al. Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Mol Cell Biol 2001;21:771-780.
27. Ristimaki A, Narko K, Hla R. Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. Biochem J 1996;318:325-331.
28. Nakano T, Ohara O, Teraoka H, et al. Glucocorticoids suppress group II phospholipase A2 production by blocking mRNA synthesis and post-transcriptional expression. J Biol Chem 1990;265: 12745-12748.
29. Vervoordeldonk MJ, Schalkwijk CG, Pfeilschifter J, et al. Effects of dexamethasone and transforming growth factor-beta 2 on group II phospholipase A2 mRNA and activity levels in interleukin 1 beta- and forskolin-stimulated mesangial cells. Biochem J 1996;315: 435-441.
30. Vadas P, Stefanski E, Wloch M, et al. Secretory non-pancreatic phospholipase A2 and cyclooxygenase-2 expression by tracheobronchial smooth muscle cells. Eur J Biochem 1996;235:557-563.
31. Andreani M, Olivier JL, Berenbaum F et al. Transcriptional regulation of inflammatory secreted phospholipases A(2). Biochim Biophys Acta 2000;1488:149-158.
32. Gotoh S, Onaya J, Abe M, et al. Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats. Ann Rheum Dis 1993;52:817-822.
33. Pisko EJ, Turner RA, Soderstrom LP, et al. Inhibition of neutrophil phagocytosis and enzyme release by hyaluronic acid. Clin Exp Rheumatol 1983;1:41-44.
34. Tobetto K, Nakai K, Akatsuka M, et al. Inhibitory effects of hyaluronan on neutrophil-mediated cartilage degradation. Connect Tissue Res 1994;29:181-190.
35. Ghosh P. The role of hyaluronic acid (hyaluronan) in health and disease: interactions with cells, cartilage and components of synovial fluid. Clin Exp Rheumatol 1994;12:75-82.
36. Akatsuka M, Yamamoto Y, Tobetto K, et al. In vitro effects of hyaluronan on prostaglandin E2 induction by interleukin-1 in rabbit articular chondrocytes. Agents Actions 1993;38:122-125.
37. 2 production in human osteoarthritic synovial cells. Agent Actions 1992;37:155-156.
38. Frean SP, Lees P. Effects of polysulfated glycosaminoglycan and hyaluronan on prostaglandin E2 production by cultured equine synoviocytes. Am J Vet Res 2000;61:499-505.
39. Tobetto K, Yasui T, Ando T, et al. Inhibitory effects of hyaluronan on [14C] arachiclonic acid release from lageled human synovial fibroblasts. Jpn J Pharmacol 1992;60:79-84.
40. Egg D. Effects of glycosaminoglycan-polysulfates and two nonsteroidal anti-inflammatory drugs on prostaglandin E2 synthesis in Chinese hamster ovary cell cultures. Pharmacol Res Commun 1983;15:709-717.
41. Tung JT, Venta PJ, Caron JP. Inducible nitric oxide expression in equine articular chondrocytes: effects of anti-inflammatory compounds. Osteoarthritis Cartilage 2002;10:5-12.
42. Lees P, Ewins CP, Taylor JBO, et al. Serum thromboxane in the horse and its inhibition by aspirin, phenylbutazone and flunixin. Br Vet J 1987;143:462-476.
43. Bocquet J, Dairequx M, Langris M, et al. Effect of a interleukin-1 like factor (mononuclear cell factor) on proteoglycan synthesis in cultured human articular chondrocytes. Biochem Biophys Res Commun 1986;134:539-549.
44. Yamada H, Kikuchi T, Nemoto O, et al. Effects of indomethacin on the production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by human articular chondrocytes. J Rheumatol 1996;23:1739-1743.